Risk Management Activities

Risk management and minimisation activities can include post-authorisation safety studies (PASS), review of the effectiveness of risk minimisation measures, monitoring pharmacovigilance risk assessment committee (PRAC) recommendations for signals and addressing PRAC safety related queries.

A risk management system is a set of pharmacovigilance activities and interventions designed to identify, characterise, prevent or minimise risks relating to medicinal products, including the assessment of the effectiveness of those interventions (EMEA/CHMP/96268/2005)

 

Regulink’s PV specialist will help with your risk management and minimisation activities:

  • Signal detection process set up
  • Signal management
  • CCSI, SmPC and PIL updates due to signal detection
  • Eudravigilance Data Analysis System (EVDAS) set up (e.g. black triangle products, PASS studies product, rare disease etc.)
  • PASS support for PV activities
  • Interim and final PASS study report reviews
  • Review risk minimisation activity effectiveness
  • Monitoring of PRAC recommendations for signals
  • Addressing safety related queries from PRAC recommendations

OTHER PHARMACOVIGILANCE SERVICES

Whether it be the longer term engagement of a contract QPPV or specific pharmacovigilance activities, Regulink is here to support you in meeting your post-authorisation and clinical trial needs. From case processing to periodic reporting, and risk management to SOP development, find out more about our services here.